Sonographic fatty liver, overweight and ischemic heart disease
- PMID: 16097054
- PMCID: PMC4398732
- DOI: 10.3748/wjg.v11.i31.4838
Sonographic fatty liver, overweight and ischemic heart disease
Abstract
Aim: To demonstrate the prevalence of sonographic fatty liver, overweight and ischemic heart disease (IHD) among the male workers in Taiwan, and to investigate the possible association of these three factors.
Methods: From July to September 2003, a total of 2 088 male aircraft-maintenance workers aged from 22 to 65 years (mean 40.5) underwent an annual health examination, including anthropometrical evaluation, blood pressure measurement, personal medical history assessment, biochemical blood analysis, abdominal ultrasonographic examination and digital electrocardiography (ECG). The Student's t-test, chi(2) test and multivariate logistic regression analysis were utilized to evaluate the relationship between IHD and salient risk factors.
Results: The all-over prevalence of overweight was 41.4%, and that of fatty liver was 29.5% (mild, moderate and severe fatty liver being 14.5%, 11.3%, and 3.7%, respectively); while the prevalence of ischemic changes on ECG was 17.1% in this study. The abnormal rates for conventional IHD risk factors including hypertension, dyslipidemia, hyperglycemia and overweight increased in accordance with the severity of fatty liver. Overweight and severity of fatty liver were independently associated with increased risks for developing IHD. Overweight subjects had a 1.32-fold (95%CI: 1.01-1.73) increased IHD risk. Participants with mild, moderate, and severe fatty liver had a 1.88-fold (95%CI: 1.37-2.6), 2.37-fold (95%CI: 1.66-3.37) and 2.76-fold (95%CI: 1.62-4.72) increased risk for developing IHD. The prevalence of ischemic ECG for the fatty liver-affected subjects with or without overweight was 30.1% and 19.1%, while that of overweight subjects free from fatty liver was 14.4%. Compared to the subjects without fatty liver nor overweight, IHD risk for the three subgroups above was as follows: OR: 2.95 (95%CI: 2.31-4.09), OR: 1.60 (95%CI: 1.07-2.39) and OR: 1.11 (95%CI: 0.78-1.56), respectively.
Conclusion: The presence of fatty liver and its severity should be carefully considered as independent risk factors for IHD. Results of the study suggest the synergistic effect between fatty liver and overweight for developing IHD. Abdominal sonographic examination may provide valuable information for IHD risk assessment in addition to limited report about liver status, especially for overweight males.
Figures
Similar articles
-
Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults.World J Gastroenterol. 2007 Mar 28;13(12):1805-10. doi: 10.3748/wjg.v13.i12.1805. World J Gastroenterol. 2007. PMID: 17465470 Free PMC article.
-
Coexistence of Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease.J Am Heart Assoc. 2023 Jul 18;12(14):e030269. doi: 10.1161/JAHA.123.030269. Epub 2023 Jul 8. J Am Heart Assoc. 2023. PMID: 37421273 Free PMC article.
-
Fatty liver and the metabolic syndrome among Shanghai adults.J Gastroenterol Hepatol. 2005 Dec;20(12):1825-32. doi: 10.1111/j.1440-1746.2005.04058.x. J Gastroenterol Hepatol. 2005. PMID: 16336439
-
Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.JAMA Intern Med. 2014 Jan;174(1):15-22. doi: 10.1001/jamainternmed.2013.10522. JAMA Intern Med. 2014. PMID: 24217719
-
Magnesium in drinking water and ischemic heart disease.Epidemiol Rev. 1997;19(2):258-72. doi: 10.1093/oxfordjournals.epirev.a017957. Epidemiol Rev. 1997. PMID: 9494787 Review.
Cited by
-
The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis.AIDS Res Hum Retroviruses. 2016 Sep;32(9):868-71. doi: 10.1089/AID.2016.0051. Epub 2016 Jun 21. AIDS Res Hum Retroviruses. 2016. PMID: 27206965 Free PMC article.
-
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.World J Gastroenterol. 2011 Jul 14;17(26):3082-91. doi: 10.3748/wjg.v17.i26.3082. World J Gastroenterol. 2011. PMID: 21912450 Free PMC article. Review.
-
Clinical significance of non-alcoholic fatty liver disease as a risk factor for prehypertension.J Korean Med Sci. 2014 Jul;29(7):973-9. doi: 10.3346/jkms.2014.29.7.973. Epub 2014 Jul 11. J Korean Med Sci. 2014. PMID: 25045230 Free PMC article.
-
Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.Am J Gastroenterol. 2008 Sep;103(9):2263-71. doi: 10.1111/j.1572-0241.2008.02034.x. Epub 2008 Aug 5. Am J Gastroenterol. 2008. PMID: 18684196 Free PMC article.
-
Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease.PLoS One. 2012;7(2):e31799. doi: 10.1371/journal.pone.0031799. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359630 Free PMC article.
References
-
- Akahoshi M, Amasaki Y, Soda M, Tominaga T, Ichimaru S, Nakashima E, Seto S, Yano K. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. Hypertens Res. 2001;24:337–343. - PubMed
-
- Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, Antonini TM, Alessandri C. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol. 2003;18:588–594. - PubMed
-
- Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, Lurie Y, Bass DD. Fatty liver--an additional and treatable feature of the insulin resistance syndrome. QJM. 1999;92:73–79. - PubMed
-
- Chilton RJ. Recent discoveries in assessment of coronary heart disease: impact of vascular mechanisms on development of atherosclerosis. J Am Osteopath Assoc. 2001;101:S1–S5. - PubMed
-
- Ganz P, Creager MA, Fang JC, McConnell MV, Lee RT, Libby P, Selwyn AP. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis. Am J Med. 1996;101:4A10S–4A16S. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical